Shinsegae, Hana Financial, Bain Capital to finance $438 mn Starfield Cheongna

Shinsegae, Hana Financial, Bain Capital to finance $438 mn Starfield Cheongna

Shinsegae Property, a subsidiary of South Korean retail giant Shinsegae Group, on Tuesday unveiled a 600 billion won ($438 million) investment agree...

Hana Asset launches ultra-low-fee Nasdaq 100 ETF

Hana Asset launches ultra-low-fee Nasdaq 100 ETF

Hana Asset Management Co. will list the “1Q US Nasdaq 100 ETF” on Tuesday, an exchange-traded fund that tracks the Nasdaq 100 index with...

Lotte Biologics signs antibody drug CMO deal with UK’s Ottimo Pharma

Lotte Biologics signs antibody drug CMO deal with UK’s Ottimo Pharma

BOSTON – Lotte Biologics Co. has signed a deal to manufacture an antibody therapy for British biotech startup Ottimo Pharma as the South Korea...

Lotte Chemical, HD Hyundai seek to combine naphtha cracking facilities

Lotte Chemical, HD Hyundai seek to combine naphtha cracking facilities

Lotte Chemical Corp. and HD Hyundai Co. are in talks to consolidate their naphtha cracking operations in South Korea’s Daesan petrochemical co...

Samsung Biologics to spin off biosimilar unit Samsung Bioepis

Samsung Biologics to spin off biosimilar unit Samsung Bioepis

Samsung Biologics Co., the world’s largest contract drugmaker, will undergo a strategic split to separate its contract development and manufac...

Samsung flexes financial muscle as insurance, card units top rankings

Samsung flexes financial muscle as insurance, card units top rankings

Samsung Group’s financial affiliates are closing in on KB Financial Group for the top spot in South Korea’s financial services sector, u...

Celltrion unveils cancer medicine to expand new drug pipelines

Celltrion unveils cancer medicine to expand new drug pipelines

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

Celltrion expands footprint in Latin America with flagship oncology drugs

Celltrion expands footprint in Latin America with flagship oncology drugs

South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...

South Korean defense industry thriving on strong overseas demand

South Korean defense industry thriving on strong overseas demand

The South Korean defense industry's current heyday is expected to continue for a while as global demand for Korean-made weapons and combat systems h...

Celltrion wins Australian approval for eye, bone disease biosimilars

Celltrion wins Australian approval for eye, bone disease biosimilars

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

Celltrion to sell autoimmune drug Stelara biosimilar at Costco in US

Celltrion to sell autoimmune drug Stelara biosimilar at Costco in US

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...

SillaJen: First to use lab-grown human tissue to find best cancer drug dose

SillaJen: First to use lab-grown human tissue to find best cancer drug dose

South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical tria...

Doosan Enerbility wins $1.5 bn in orders from Saudi Arabia

Doosan Enerbility wins $1.5 bn in orders from Saudi Arabia

Doosan Enerbility Co., South Korea’s leading gas turbine maunfacturer for power plants, said on Thursday that it has secured a combined $1.5 b...

Chong Kun Dang to build new plant for foray into biologics market

Chong Kun Dang to build new plant for foray into biologics market

Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...

Celltrion wins EU approval for autoimmune disease treatment Avtozma

Celltrion wins EU approval for autoimmune disease treatment Avtozma

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

Lotte Biologics eyes first ADC CDMO order in 2025

Lotte Biologics eyes first ADC CDMO order in 2025

SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will seek to wi...

Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut

Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

SK Biopharmaceuticals, Eurofarma to set up AI epilepsy platform JV in US

SK Biopharmaceuticals, Eurofarma to set up AI epilepsy platform JV in US

South Korea’s SK Biopharmaceuticals Co. has signed a deal with Brazil’s Eurofarma Laboratórios S.A. to establish a joint venture ...

Korean drugmakers control more than half of European biosimilar market

Korean drugmakers control more than half of European biosimilar market

South Korea’s two leading drugmakers, Celltrion Inc. and Samsung Bioepis Co., have achieved a significant milestone in the European biosimilar...

Yuhan’s lung cancer drug gets OK in Europe

Yuhan’s lung cancer drug gets OK in Europe

Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...

Celltrion’s 4 new biosimilars win EU approval recommendation

Celltrion’s 4 new biosimilars win EU approval recommendation

Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...

Boryung, Lotus Pharma signs CDMO deal on anticancer injection

Boryung, Lotus Pharma signs CDMO deal on anticancer injection

South Korea's Boryung Corp. said on Thursday it signed a contract with Lotus Pharmaceutical, a Taiwanese oncology firm, for contract development and...

SK Biopharm submits NDA of epilepsy drug to China

SK Biopharm submits NDA of epilepsy drug to China

South Korea's SK Biopharmaceuticals Co. said on Tuesday it submitted the new drug application (NDA) for its flagship epilepsy drug Cenobamate to Chi...

Eximbank of Korea to commit $143 mn to 4 Korean PEs

Eximbank of Korea to commit $143 mn to 4 Korean PEs

IMM Investment, Korea Investment Private Equity (PE), Corstone Asia, and Paratus Investment have been selected for the Export-Import Bank of Korea's...

Celltrion’s Remsima on course to become Korea’s 1st blockbuster drug

Celltrion’s Remsima on course to become Korea’s 1st blockbuster drug

Celltrion Inc.'s Remsima, the world’s first biosimilar monoclonal antibody, is on track to exceed 1 trillion won ($713 million) in sales this ...

Hanmi Pharma to move up launch of anti-obesity drug

Hanmi Pharma to move up launch of anti-obesity drug

South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...

Samsung Biologics wins $668 million CDMO deal with European pharma

Samsung Biologics wins $668 million CDMO deal with European pharma

Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...

KEPCO, LS Electric to co-work on predictive diagnostics solutions

KEPCO, LS Electric to co-work on predictive diagnostics solutions

Korea Electric Power Corp. (KEPCO), the South Korean state-run utility company, said on Thursday it signed a memorandum of understanding (MOU) with ...

S.Korea's Solus mass-produces copper foil in Hungary

S.Korea's Solus mass-produces copper foil in Hungary

Solus Advanced Materials, a South Korean copper foil supplier, said on Tuesday it started mass production at its second plant in Hungary, Europe&rsq...

LG Uplus publishes white paper on 6G services

LG Uplus publishes white paper on 6G services

South Korea's LG Uplus Corp. said on Wednesday the release of its "6G White Paper: Non-Terrestrial Networks," which explores the future direction of...

Kakao Pay backs out of acquisition deal for SSG Pay, Smile Pay Hanwha in talks to buy five-star hotel Paraspara Seoul Kia's Lego-like PV5 with 16 variants to hit market in July Stray Kids make K-pop history with landmark stadium show in Germany S.Korea’s most prominent business leader returns with all charges cleared